Clinical Trials Browser

Phase 1/2 × Breast Neoplasms × Afatinib × Clear all

NCT02768337 2024-01-31

CamBMT1

Phase 1/2 Terminated

BreastCNSThoracic

Brain Neoplasms, Breast Neoplasms, Lung Neoplasms